| Literature DB >> 29047087 |
Christina M Pabelick1,2, Michael A Thompson3, Rodney D Britt4.
Abstract
Although it is necessary and part of standard practice, supplemental oxygen (40-90% O2) or hyperoxia is a significant contributing factor to development of bronchopulmonary dysplasia, persistent pulmonary hypertension, recurrent wheezing, and asthma in preterm infants. This chapter discusses hyperoxia and the role of redox signaling in the context of neonatal lung growth and disease. Here, we discuss how hyperoxia promotes dysfunction in the airway and the known redox-mediated mechanisms that are important for postnatal vascular and alveolar development. Whether in the airway or alveoli, redox pathways are important and greatly influence the neonatal lung.Entities:
Keywords: Alveologenesis; Heme oxygenase-1; Hyperoxia; Hypoxia inducible factor nitric oxide; Lung development; Nuclear factor E2-related factor 2; Pulmonary vasculogenesis redox signaling; Soluble guanylate cyclase; Vascular endothelial growth factor
Mesh:
Year: 2017 PMID: 29047087 DOI: 10.1007/978-3-319-63245-2_11
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622